3122. Phase III, Randomized Study of Atezolizumab Plus Bevacizumab and Chemotherapy in Patients With EGFR- or ALK-Mutated Non-Small-Cell Lung Cancer (ATTLAS, KCSG-LU19-04)
Sehhoon Park 1, Tae Min Kim 2, Ji-Youn Han 3, Gyeong-Won Lee 4, Byoung Yong Shim 5, Yun-Gyoo Lee 6, Sang-We Kim 7, Il Hwan Kim 8, Suee Lee 9, Yu Jung Kim 10, Ji Hyun Park 11, Sang-Gon Park 12, Ki Hyeong Lee 13, Eun Joo Kang 14, Ju Won Kim 15, Seong-Hoon Shin 16, Chan-Young Ock 17, Byung-Ho Nam 18, Jaebong Lee 19, Hyun-Ae Jung 1, Jong-Mu Sun 1, Se-Hoon Lee 1, Jin Seok Ahn 1, Myung-Ju Ahn 1
J Clin Oncol
. 2023 Oct 20:JCO2301891.
Link